Using antibiotics to prevent infections in patients with gastric varices undergoing treatment
Official title: Antibiotic Prophylaxis in Patients Undergoing Endoscopic Injection of Cyanoacrylate for Primary and Secondary Prevention of Gastric Variceal Bleeding
Run by Taipei Veterans General Hospital, Taiwan · NCT04140578 · Data updated 2026-11-12
This study is testing if giving antibiotics to patients with liver disease and gastric varices during treatment can help prevent infections and reduce the chances of bleeding again.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 20 Years to 85 Years |
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | Taipei Veterans General Hospital, Taiwan Government |
| Locations | 1 site (Taipei) |
| Status | Recruiting |
| Started | January 28, 2017 |
| Main results expected | December 31, 2030 |
| Study ends | December 31, 2030 |
| Registry record updated | October 28, 2019 |
| Trial ID | NCT04140578 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients aged 20 to 85 with liver cirrhosis or hepatoma who have gastric varices but no esophageal varices.
✕Probably not a fit
Patients with terminal illnesses affecting major organ systems, recent antibiotic use, or suspected infections may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to determine the necessity of antibiotic prophylaxis in patients with chronic liver disease and gastric varices who are treated with endoscopic variceal obturation (GVO). The study will involve a randomized approach to assess the effectiveness of Ertapenem in preventing septic infections and reducing the rebleeding rate associated with gastric variceal bleeding. Given the high rebleeding rates and potential complications from current treatment methods, this trial seeks to clarify the role of antibiotics in improving patient outcomes. Participants will be closely monitored for any adverse effects and treatment efficacy.
Why it matters
Potential benefit: If successful, this study could significantly reduce the risk of infections and rebleeding in patients with gastric varices, improving their overall treatment outcomes.
How similar studies have gone: Other studies have explored antibiotic prophylaxis in similar contexts, but this specific approach using Ertapenem in gastric varices is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients with live cirrhosis and/or hepatoma 2. Aged 20 to 85, who had endoscopy-treatment EV(-)GV(+)or EV\<GV Exclusion Criteria: 1. Had a terminal illness of any major organ system,such as heart failure, kindey failure,COPD 2. Patients recieve antibiotics recently. 3. Patients suspected infection.
Where it's running
-
Veteran General Hospital-Taipei
Taipei, Taiwan Recruiting
Study contacts
- Principal investigator: Ming-Chih Hou — Taipei Veterans General Hospital, Taiwan
- Study coordinator: Ming-Chih Hou, MD
- Email: mchou@vghtpe.gov.tw
- Phone: 886-2-28712111
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Triage performance and physiological predictors of serious illness in febrile children in the pediatric emergency department
This study tests whether the initial color-coded triage category and vital signs at triage can predict serious outcomes in febrile children who come to pediatric emergency departments in Turkey.
-
Ruta C and Vitamin C in Sepsis: Adding antioxidants to standard care
This trial tests whether adding Ruta C (rutin plus vitamin C) or vitamin C alone to standard sepsis treatment helps adults in the ICU stay shorter and recover better.
-
Early detection of sepsis-related blood clotting problems in severe burn patients
This study tests how well the JAAM-2 score can detect sepsis-induced coagulopathy early in adults with severe burns who develop sepsis in the ICU.
-
Neutrophil EMR3 as a biomarker for sepsis in ICU patients
Researchers will test whether measuring EMR3 on neutrophils helps diagnose sepsis, monitor progression, and predict outcomes in adults in Chinese ICUs.
-
See if Buzzy and virtual reality help kids get IV lines faster
This study tests whether a vein-imaging device plus virtual reality or the same device plus a pain-reducing tool can make peripheral IV placement easier for children aged 7–12 with fever.
-
Thymalfasin added to standard care for adults with sepsis and immune dysfunction
This study tests whether thymosin alpha-1 helps restore immune function in adults with sepsis who have weakened immunity.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.